9 July 2007
Memphis, Tenn. - Smith & Nephew, Inc. (NYSE: SNN, LSE, SN) Orthopaedic Reconstruction business today announced the global launch of the JOURNEY◊ DEUCE◊ Bi-Compartmental Knee System. The JOURNEY◊ DEUCE◊ Knee System is a new, innovative solution that may give nearly 70% of all patients receiving a total knee replacement a more minimally invasive, bone and ligament preserving treatment alternative.
"The JOURNEY◊ DEUCE◊ Knee System is an innovative product that provides a unique option for surgeons and patients. By preserving the cruciate ligaments, we would expect the JOURNEY◊ DEUCE◊ Knee System to feel and bend more like their normal knee than any other implant available," said surgeon inventor Dr. Lindsey Rolston, of Henry County Center for Orthopedic Surgery & Sports Medicine in New Castle, Ind.
The implant is called the "DEUCE" because it replaces only the two areas of the knee most commonly affected by osteoarthritis while keeping the third area intact. Since 2003, 1.8 million Americans have had their ACL replaced, which can lead patients to feel instability and abnormal motion in their knees. But now JOURNEY◊ DEUCE◊ Knee System offers another important benefit and allows the surgeon to keep their patient's anterior cruciate ligament (ACL) intact.
"With the retention of the anterior and posterior cruciate ligaments, the JOURNEY◊ DEUCE◊ knee system addresses an unmet need in the market for the active, informed patient who may be concerned about potential reduced knee function and mobility with a total knee," said Joseph DeVivo, president, Smith & Nephew Orthopaedic Reconstruction. "The JOURNEY◊ DEUCE◊ knee system provides a bone-conserving alternative to a total knee replacement, while allowing for earlier intervention and preserving all future surgery options for patients, including a total knee replacement."
Traditional total knee replacement resurfaces and replaces the ends of the thigh bone (femur), shin bone (tibia) and knee cap (patella). However, one study has indicated that up to 70% of the disease in osteoarthritic knees is limited to the knee cap and the inner portion of the thigh and shin bone (the medial compartment). The JOURNEY◊ DEUCE◊ Knee System treats only the diseased areas—the kneecap and medial compartment—while leaving the lateral portion of the femur and tibia untouched.
Exclusive to Smith & Nephew, The JOURNEY◊ DEUCE◊ Bi-Compartmental Knee System is the only FDA cleared knee system to replace two of the three knee compartments. Financial analyst firm, Wachovia, called JOURNEY◊ DEUCE◊ Knee System the "most innovative reconstructive product" at the 2007 American Academy of Orthopedic Surgeons Annual Meeting (AAOS) in San Diego, CA. It is available in OXINIUM◊ Oxidized Zirconium, Smith & Nephew's exclusive bearing surface that has been shown to reduce wear up to 85%, thereby potentially increasing the longevity of the implant.
The JOURNEY◊ DEUCE◊ Bi-Compartmental Knee System is being launched in the United States, Canada, Australia and Europe. Nearly 200 non-design team surgeons have been trained on the system to date.
The JOURNEY◊ DEUCE◊ Knee System is part of a family of next generation products from Smith & Nephew that aim to restore more natural motion through implants that preserve bone and ligaments or replace them with more anatomic components. Other products in the group include the JOURNEY◊ PFJ Patello-Femoral Replacement and the JOURNEY◊ BCS Bi-Cruciate Stabilized Total Knee System, which was Wachovia's pick for most innovative reconstruction product at AAOS 2006.
2006 AAOS Annual Meeting Poster #P181